Helen Passant

419 total citations
5 papers, 64 citations indexed

About

Helen Passant is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Helen Passant has authored 5 papers receiving a total of 64 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pulmonary and Respiratory Medicine, 2 papers in Surgery and 2 papers in Oncology. Recurrent topics in Helen Passant's work include HER2/EGFR in Cancer Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Helen Passant is often cited by papers focused on HER2/EGFR in Cancer Research (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Cancer Treatment and Pharmacology (2 papers). Helen Passant collaborates with scholars based in United Kingdom. Helen Passant's co-authors include Somnath Mukherjee, John Bridgewater, Chris Hurt, Stephen P. Pereira, Matthew T. Huggett, Joanne Haviland, A.N. Harnett, Adrian Murray Brunt, Duncan Wheatley and Mark Sydenham and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Clinical Oncology and Tumori Journal.

In The Last Decade

Helen Passant

5 papers receiving 64 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Helen Passant United Kingdom	4	44	31	21	16	11	5	64
Petra Flygare Sweden	5	39 0.9×	34 1.1×	14 0.7×	23 1.4×	10 0.9×	8	73
Joycelin Canavan United States	3	27 0.6×	13 0.4×	21 1.0×	16 1.0×	15 1.4×	5	64
G. Salvi Italy	6	39 0.9×	51 1.6×	21 1.0×	31 1.9×	17 1.5×	20	97
Philip Camilleri United Kingdom	7	20 0.5×	65 2.1×	8 0.4×	17 1.1×	18 1.6×	11	97
Joel Berends United States	4	36 0.8×	33 1.1×	7 0.3×	17 1.1×	13 1.2×	7	68
Harold Yoon Canada	3	41 0.9×	63 2.0×	16 0.8×	14 0.9×	26 2.4×	5	89
Ana Beatriz Kinupe Abrahão Canada	5	87 2.0×	45 1.5×	9 0.4×	23 1.4×	9 0.8×	10	114
Nick Wadd United Kingdom	5	45 1.0×	30 1.0×	9 0.4×	28 1.8×	8 0.7×	10	83
Keiko Murofushi Japan	5	49 1.1×	34 1.1×	24 1.1×	35 2.2×	27 2.5×	10	99
J.J. Lee United States	4	32 0.7×	35 1.1×	6 0.3×	12 0.8×	10 0.9×	11	57

Countries citing papers authored by Helen Passant

Since Specialization

Citations

This map shows the geographic impact of Helen Passant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Passant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Passant more than expected).

Fields of papers citing papers by Helen Passant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen Passant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Passant. The network helps show where Helen Passant may publish in the future.

Co-authorship network of co-authors of Helen Passant

This figure shows the co-authorship network connecting the top 25 collaborators of Helen Passant. A scholar is included among the top collaborators of Helen Passant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen Passant. Helen Passant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Seligmann, Jenny F., Alexandra Wright‐Hughes, Galina Velikova, et al.. (2020). Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial. Clinical Oncology. 32(10). 656–664. 12 indexed citations

2.

Brunt, Adrian Murray, Joanne Haviland, Mark Sydenham, et al.. (2018). FAST Phase III RCT of Radiotherapy Hypofractionation for Treatment of Early Breast Cancer: 10-Year Results (CRUKE/04/015). International Journal of Radiation Oncology*Biology*Physics. 102(5). 1603–1604. 34 indexed citations

3.

Huggett, Matthew T., Helen Passant, Chris Hurt, et al.. (2014). Outcome and patterns of care in advanced biliary tract carcinoma (ABC): experience from two tertiary institutions in the United Kingdom.. PubMed. 100(2). 219–24. 9 indexed citations

4.

Huggett, Matthew T., Helen Passant, Chris Hurt, et al.. (2014). Outcome and Patterns of Care in Advanced Biliary Tract Carcinoma (ABC): Experience from Two Tertiary Institutions in the United Kingdom. Tumori Journal. 100(2). 219–224. 7 indexed citations

5.

Passant, Helen & Annabel Borley. (2013). Adjuvant treatment for breast cancer. Surgery (Oxford). 31(1). 37–40. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact